The ConcePTION project: bridging the gap

Up to 90% of women take medication at some stage during pregnancy and breastfeeding. Even though many of those medicines are safe to use, only 3,7% of them are explicitly labelled as safe. 1 in 3 choose to discontinue treatment, with potentially serious consequences to their health. With around 5,000,000 pregnancies in Europe ever year, the number of women who are affected is staggering. Of the available medicines, 71% include no information on use when pregnant, and 83% include no information on use when breastfeeding. Of the women, 25% experience anxiety due to a lack of information about medicines. 52% encounter inconsistencies in the available information, 40% report difficulty understanding what is available, and 20% cannot find any relevant information at all.

About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.

Reporting medicine use in pregnancy

Did you use any medicines when you were pregnant? Here is how you and your health care provider can report what we call an exposure.

Ten principles for stakeholder engagement in the ConcePTION project

The ConcePTION project is building much-needed knowledge for women and health care professionals. To achieve our goal of building an ecosystem for medicine safety in pregnancy and breastfeeding, we need to engage with women, their partners, their doctors, pharmacists, midwives and nurses, the companies that develop medicines and the authorities that approve them and decide what becomes available to patients. Our goal is to work in an open and inclusive way, with the spirit of mutual respect and trust. Here is how we engage with stakeholders in an ethical way.

News

Oct
03
2024
The 23rd ISoP Annual Meeting is held 1-5 October in Montreal, and is exploring global perspectives on pharmacovigilance in the digital age and advance therapeutics. Today, Miriam Sturkenboom, coordinator of the ConcePTION project and professor at University Medical Center Utrecht in Netherlands, will present the ConcePTION project and showcase the learning health care ecosystem created. | READ MORE >>
Sep
24
2024
We believe that access to trusted information about the safety of medicines during pregnancy is a fundamental human right. One that is not currently being met. The ConcePTION project have developed two important resources to help bridge this gap: the MUMS knowledge bank and e-learning for health care professionals. Join our webinar on 10 October at 14 CEST to learn more about these resources! | READ MORE >>
Sep
02
2024
The ConcePTION project has validated a novel method to evaluate the quality of real-world pregnancy pharmacovigilance data. The validation is based on 186 case reports. The results are published in Drug Safety, and represents an advancement in how data on medication safety during pregnancy is collected and assessed. | READ MORE >>

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.

OUR CONSORTIUM
»

The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.